Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysisResearch in context

Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysisResearch in context

Summary: Background: Cancer-related cognitive decline is a serious problem in long-term survival but no pivotal study has investigated whether checkpoint inhibitors (ICI) may be associated with cognitive adverse events. Methods: This propensity score-matched analysis recruited non-small cell lung c...

Full description

Bibliographic Details
Main Authors: Yifei Ma, Nianqi Liu, Yanqi Wang, Ao Zhang, Zirui Zhu, Zhiying Zhang, Yiming Li, Guangmin Jian, Guangzhen Fu, Mingming Dong, Guoxing Zheng, Pengfei Zhu, Guanqing Zhong, Shenrui Bai, Shuqin Chen, Xiaolong Wei, Jifan Tan, Xinjia Wang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:EClinicalMedicine
Subjects:
Checkpoint inhibitor
Cognitive adverse events
Minimal clinically important difference
Propensity score matching
Immune-related adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023001645

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023001645

Similar Items